A Multi-Concept Theme for Digital Agencies and Startups
Ministry of Health and Family Welfare has issued a directive to ban the manufacture, sale, and distribution of the fixed dose combination drug Amylase + Protease + Glucoamylase + Pectinase + Alpha Galactosidase + Lactase + Beta-Gluconase + Cellulase + Lipase + Bromelain + Xylanase + Hemicellulase + Malt diastase + Invertase + Papain, Antimony Potassium Tartrate + Dried Ferrous Sulphate, Benfotiamine + Silymarin + L-Ornithine L-aspartate + Sodium Selenite + Folic acid + Pyridoxine hydrochloride, Bismuth Ammonium Citrate + Papain, Cyproheptadine HCl + Thiamine HCl + Riboflavine + Pyridoxine HCl + Niacinamide, Cyproheptadine Hydrochloride + Tricholine Citrate + Thiamine Hydrochloride + Riboflavine + Pyridoxine Hydrochloride, Rabeprazole Sodium (As enteric coated tablet) + Clidinium Bromide + Dicyclomine HCl + Chlordiazepoxide, Fungal Diastase + Papain + Nux vomica Tincture + Cardamom Tincture + Casein Hydrolysed + Alcohol, Mefenamic Acid + Paracetamol Injection, Omeprazole Magnesium + Dicyclomine HCl, S-adenosyl methionine + Metadoxine + Ursodeoxycholicacid BP + L-Methylfolate Calcium eq. to L-Methylfolate + Choline bitartratee + Silymarin + L-ornithine L-aspartate + Inositol + Taurine, Silymarin + Thiamine Mononitrate + Riboflavin+ Pyridoxine HCl + Niacinamide + Calcium pantothenate + Vitamin B12, Silymarin + Pyridoxine HCl + Cyanocobalamin + Niacinamide + Folic Acid, Silymarin + Vitamin B6 + Vitamin B12 + Niacinamide + Folic acid + Tricholine Citrate for human use. By virtue of the circular, this action is based on recommendations from the Drugs Technical Advisory Board and the powers granted under section 26A of the Drugs and Cosmetics Act, 1940. The drug is deemed to have no therapeutic benefit and may pose risks to human health. Please refer to the attached document for more details.
Request a Demo
IFSCA has issued Master Circular for recognised Stock Exchanges and recognised Clearing Corporations Key highlights of this circular are: 1
RBI has issued circular regarding Investments by Foreign Portfolio Investors in Government Securities Key highlights of this circular are:
CERSAI has issued notification regarding CKYCRR 2.0 API integration & Reporting entity onboarding guide Through this notification, 2.0 vers
FEMA has issued Foreign Exchange Management (Export of Goods and Services) (First Amendment) Regulations, 2026 Through this notification, u
Thank You for your interest in Complinity. Your CV has been forwarded to HR. In case your profile is shortlisted, HR shall contact you.
Thank You for your interest in Complinity. Your CV has been forwarded to HR.